{"schema_version":"1.0","hypothesis_id":37832,"triple":{"drug":"tofacitinib","drug_canonical":"tofacitinib","mediator":"JAK-STAT pathway","mediator_canonical":"jak-stat pathway","outcome":"Alzheimer's disease","outcome_canonical":"Alzheimer disease"},"domain":{"domain":"cross_domain","source":"rheumatoid_arthritis","target":"alzheimer"},"provenance_completeness":"partial_backfill","completeness_notes":"Backfilled retroactively from DB state on 2026-05-13. The pipeline_run this row references was created by the backfill script, not by the actual generation orchestrator. Source papers, claims, scoring, and embedding config are recovered; generation-time metadata (exact git commit at gen time, host, exact command) is not recoverable.","source_papers":[{"doi":"10.4103/ijd.ijd_842_24","pmid":"40162359","year":2025,"roles":["drug_mediator"],"title":"Successful Use of Tofacitinib in Paediatric Prurigo Nodularis: A Report of Four Cases","journal":"Indian J Dermatol","work_id":293821,"publication_date":"2025-02-27"},{"doi":"10.1002/mco2.538","pmid":"38617436","year":2024,"roles":["drug_mediator"],"title":"Tofacitinib for elderly onset hemophagocytic lymphohistiocytosis with gene mutations: a case report","journal":"MedComm (2020)","work_id":302483,"publication_date":"2024-04-01"},{"doi":"10.1080/09546634.2024.2338281","pmid":"38632962","year":2024,"roles":["drug_mediator"],"title":"Tofacitinib for managing granuloma formation after dermal filler injection: three case reports and literature review","journal":"J Dermatolog Treat","work_id":298002,"publication_date":"2024-04-18"},{"doi":"10.3389/fimmu.2024.1457821","pmid":"39439798","year":2024,"roles":["drug_mediator"],"title":"Tofacitinib for child-onset systemic lupus erythematosus","journal":"Front Immunol","work_id":293127,"publication_date":"2024-10-08"},{"doi":"10.1186/s12967-024-05617-6","pmid":"39210332","year":2024,"roles":["drug_mediator"],"title":"Tofacitinib for the treatment of immune-related adverse events in cancer immunotherapy: a multi-center observational study","journal":"J Transl Med","work_id":287958,"publication_date":"2024-08-29"},{"doi":"10.1002/ccr3.8066","pmid":"37854265","year":2023,"roles":["drug_mediator"],"title":"Successful treatment of resistant plantar ulcerative lichen planus with tofacitinib: A case report and comprehensive review of the literature","journal":"Clin Case Rep","work_id":291569,"publication_date":"2023-10-01"},{"doi":"10.3389/fimmu.2022.944013","pmid":"36189247","year":2022,"roles":["drug_mediator"],"title":"Case Report: Treatment for steroid-refractory immune-related myocarditis with tofacitinib","journal":"Front Immunol","work_id":295403,"publication_date":"2022-09-15"},{"doi":"10.1080/09546634.2022.2082355","pmid":"35642323","year":2022,"roles":["drug_mediator"],"title":"Tofacitinib in the treatment of refractory eczemas – a case series","journal":"J Dermatolog Treat","work_id":293005,"publication_date":"2022-05-31"},{"doi":"10.1093/cei/uxac085","pmid":"36124688","year":2022,"roles":["drug_mediator"],"title":"Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response","journal":"Clin Exp Immunol","work_id":290628,"publication_date":"2022-09-17"},{"doi":"10.1111/dth.15848","pmid":"36175135","year":2022,"roles":["drug_mediator"],"title":"Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: A retrospective case series","journal":"Dermatol Ther","work_id":289994,"publication_date":"2022-09-30"},{"doi":"10.3389/fped.2022.820586","pmid":"35211430","year":2022,"roles":["drug_mediator"],"title":"The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience","journal":"Front Pediatr","work_id":287398,"publication_date":"2022-02-08"},{"doi":"10.3389/fimmu.2021.738481","pmid":"34630419","year":2021,"roles":["drug_mediator"],"title":"Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response","journal":"Front Immunol","work_id":286775,"publication_date":"2021-09-24"},{"doi":"10.3390/cells8050425","pmid":"31072055","year":2019,"roles":["mediator_outcome"],"title":"Genetic and Real-World Clinical Data, Combined with Empirical Validation, Nominate Jak-Stat Signaling as a Target for Alzheimer’s Disease Therapeutic Development","journal":"Cells","work_id":62206,"publication_date":"2019-05-08"},{"doi":"10.1093/rheumatology/key366","pmid":"30608616","year":2018,"roles":["drug_mediator"],"title":"Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib","journal":"Rheumatology (Oxford)","work_id":286496,"publication_date":"2018-11-13"}],"source_paper_count":14,"extracted_claims":[{"side":"drug_mediator","object":"JAK-STAT pathway","context":"in refractory cutaneous dermatomyositis","subject":"tofacitinib","work_id":286496,"claim_id":207403,"polarity":"positive","predicate":"inhibits","confidence":0.95,"extraction_run_id":29},{"side":"drug_mediator","object":"JAK-STAT pathway","context":"in rheumatoid arthritis patients in vivo","subject":"tofacitinib","work_id":286775,"claim_id":208121,"polarity":"positive","predicate":"suppresses","confidence":0.9,"extraction_run_id":29},{"side":"drug_mediator","object":"JAK-STAT pathway","context":"in the treatment of pediatric rheumatic diseases","subject":"Tofacitinib","work_id":287398,"claim_id":209567,"polarity":"positive","predicate":"inhibits","confidence":0.9,"extraction_run_id":29},{"side":"drug_mediator","object":"JAK-STAT pathway","context":"general","subject":"tofacitinib","work_id":287958,"claim_id":211201,"polarity":"positive","predicate":"inhibits","confidence":0.9,"extraction_run_id":29},{"side":"drug_mediator","object":"JAK-STAT pathway","context":"in rosacea patients","subject":"tofacitinib","work_id":289994,"claim_id":220252,"polarity":"positive","predicate":"inhibits","confidence":0.9,"extraction_run_id":29},{"side":"drug_mediator","object":"JAK-STAT pathway","context":"in rheumatoid arthritis patients","subject":"tofacitinib","work_id":290628,"claim_id":222750,"polarity":"positive","predicate":"inhibits","confidence":0.95,"extraction_run_id":29},{"side":"drug_mediator","object":"JAK-STAT pathway","context":"general mechanism","subject":"tofacitinib","work_id":291569,"claim_id":226845,"polarity":"positive","predicate":"inhibits","confidence":0.99,"extraction_run_id":29},{"side":"drug_mediator","object":"JAK-STAT pathway","context":"in treatment of dermatoses","subject":"tofacitinib","work_id":293005,"claim_id":232459,"polarity":"positive","predicate":"inhibits","confidence":0.7,"extraction_run_id":29},{"side":"drug_mediator","object":"JAK-STAT pathway","context":"in child-onset systemic lupus erythematosus","subject":"Tofacitinib","work_id":293127,"claim_id":232961,"polarity":"positive","predicate":"inhibits","confidence":0.9,"extraction_run_id":29},{"side":"drug_mediator","object":"JAK-STAT pathway","context":"in prurigo nodularis","subject":"tofacitinib","work_id":293821,"claim_id":235508,"polarity":"positive","predicate":"inhibits","confidence":0.9,"extraction_run_id":29},{"side":"drug_mediator","object":"JAK-STAT pathway","context":"in steroid-refractory immune-related myocarditis patient","subject":"tofacitinib","work_id":295403,"claim_id":241466,"polarity":"positive","predicate":"inhibits","confidence":0.9,"extraction_run_id":29},{"side":"drug_mediator","object":"JAK-STAT pathway","context":"cutaneous granulomatous disorders (literature review)","subject":"tofacitinib","work_id":298002,"claim_id":248484,"polarity":"positive","predicate":"downregulates","confidence":0.6,"extraction_run_id":29},{"side":"drug_mediator","object":"JAK-STAT pathway","context":"HLH therapy","subject":"tofacitinib","work_id":302483,"claim_id":261743,"polarity":"positive","predicate":"inhibits","confidence":0.8,"extraction_run_id":29},{"side":"mediator_outcome","object":"Alzheimer's disease","context":"clinical data from six million patients","subject":"JAK-STAT pathway","work_id":62206,"claim_id":42173,"polarity":"positive","predicate":"correlates_with","confidence":0.7,"extraction_run_id":16}],"extracted_claim_count":14,"extraction":{"model":"deepseek-v4-flash","model_source":"configured","prompt_version":"v1_2026_05_07","run_ids":[16,29]},"bridge":{"a_to_b_predicate":"inhibits","b_to_c_predicate":"correlates_with","a_to_b_evidence_count":13,"b_to_c_evidence_count":1,"edge_support_log_ab":2.6390573296152584,"edge_support_log_bc":0.6931471805599453,"novelty_factor":1.0,"direct_a_to_c_count":0},"embedding":{"model":"bge-m3","dim":1024,"max_length":8192,"similarity_scores":{}},"scoring":{"method":"swanson_abc_log_evidence_with_novelty_penalty","formula":"score = min((log(ab+1) + log(bc+1)) * novelty / 10, 1.0); novelty = 1.0 if direct==0 else 0.7 / (direct+1)","score_raw":0.3332204510175204,"score":0.3332204510175204,"quality_tier":"high","quality_reason":null},"pipeline_run":{"id":4,"run_uuid":"eb8b7730-d92e-4cd5-95dd-95f6c5d62cc2","command":"scripts/backfill_provenance_v2.py:v2_2026_05_12","status":"completed","git_commit":"9996ffaa56e9b7cd5f677bd8203624c2c18aa000","host":"MacBook-Pro-Daniel96.local","started_at":"2026-05-12T21:35:53.363326+00:00","ended_at":"2026-05-12T21:43:41.903387+00:00","notes":"Retroactive provenance backfill on 2026-05-13 for snapshot v2_2026_05_12. Synthetic pipeline_runs row — original generation run records are lost (pre-date provenance schema). All recoverable fields populated from current DB state (claims, works, repurposing_hypotheses); pipeline_run record is synthetic, hence completeness='partial_backfill'.\nBackfilled 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.","domains":["als","alzheimer","depression","epilepsy","glioblastoma","inflammatory_bowel_disease","multiple_sclerosis","pancreatic_cancer","rheumatoid_arthritis","type_2_diabetes"]},"generated_at":"2026-05-12T21:43:40.945575+00:00"}